---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-022890"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:13:58.672661+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Beauty Health shareholders pass all three proposals at 2023 annual meeting

## Summary
- All three Class II director nominees (Capellas, Few, Miller) re-elected to three-year terms.
- Deloitte & Touche ratified as independent auditor for FY 2023 with over 99.6% of votes cast.
- Advisory say-on-pay resolution approved with over 99.6% of votes cast.
- Over 91.9% of outstanding shares represented at the meeting.

## SEC filing metadata
- accession: 0001628280-23-022890
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828023022890/0001628280-23-022890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828023022890/skin-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-022890
- JSON: https://secwatch.observer/filing/0001628280-23-022890.json
- Plain text: https://secwatch.observer/filing/0001628280-23-022890.txt

## Key facts
- Shareholder Votes
  SkinHealth Systems Inc. shareholders approved Advisory Vote on the Compensation of the Named Executive Officers at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Proposal No. 3 : Advisory Vote on the Compensation of the Named Executive Officers The Company’s stockholders approved, on an advisory, non-binding basis, the compensation paid by the Company to its named executive officers as disclosed in the Proxy Statement, as follows: Votes For Votes Against Abstentions Broker Non-Votes 113,454,143 425,849 23,712 7,996,142
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023022890/0001628280-23-022890-index.htm
- Shareholder Votes
  SkinHealth Systems Inc. shareholders approved Election of Class II Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Proposal No. 1 : Election of Class II Directors The Company’s stockholders re-elected each of the three Class II directors listed below, each to hold office for a period of three years until the Company’s 2026 annual meeting of stockholders, or until his successor is duly appointed or elected and qualified, subject to prior death, resignation, or removal, as follows: Nominees Votes For Votes Withheld Broker Non-Votes Michael D. Capellas 82,219,150 31,684,554 7,996,142 Dr. Julius Few 91,102,606 22,801,098 7,996,142 Brian Miller 90,921,951 22,981,753 7,996,142
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023022890/0001628280-23-022890-index.htm
- Shareholder Votes
  SkinHealth Systems Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent, registered public accounting firm for the fiscal year ending December 31, 2023, as follows: Votes For Votes Against Abstentions Broker Non-Votes 121,409,900 485,100 4,846 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023022890/0001628280-23-022890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.